- Center on Health Equity and Access
- Clinical
- Health Care Cost
- Health Care Delivery
- Insurance
- Policy
- Technology
- Value-Based Care
Psychological, Social Issues Dr Brian Vickery Sees With His Patients With Food Allergies
Despite a patient's vigilance, there is an unpredictable risk of an accidental reaction from an exposure, explained Brian Vickery, MD, associate professor of pediatrics at Emory University and director of the Food Allergy Center, Children’s Healthcare of Atlanta.
Despite a patient's vigilance, there is an unpredictable risk of an accidental reaction from an exposure, explained Brian Vickery, MD, associate professor of pediatrics at Emory University and director of the Food Allergy Center, Children’s Healthcare of Atlanta.
Transcript
What are some psychological and social issues your patients with food allergies cope with?
The burdens of eliminating these foods from their diet is difficult but can be managed. I think the main thing is that there is an unpredictable risk of an accidental reaction from an exposure despite their vigilance, and we know that from longitudinal studies. It is simple to say, “just avoid the food and you’ll be fine.” In practice, it’s really difficult to do that, and that means that patients are at risk. They typically eat 3-5 times a day, and they are at an unpredictable risk for a potentially life-threatening situation, and that risk is compounded by the fact that they themselves must evaluate the situation and administer a rescue medication, get them to the hospital if they need to, and basically act as a first responder to keep themselves safe. That’s a tremendous burden to carry around. It’s a tremendous stress. I think people are really concerned about the possibility of a life-threatening situation developing, and this is what we consistently hear over and over from patients.
Looking Back on ISPOR 2024: Hot Policy Topics, Welcome Focus on Employers, and More
May 10th 2024Kimberly Westrich, MA, chief strategy officer of the National Pharmaceutical Council, reflects on the most valuable learnings from the 2024 meeting of ISPOR—The Professional Society for Health Economics and Outcomes Research, including lively discussions of the Inflation Reduction Act and workshops on value assessment.
Read More
The Importance of Examining and Preventing Atrial Fibrillation
August 29th 2023At this year’s American Society for Preventive Cardiology Congress on CVD Prevention, Emelia J. Benjamin, MD, ScM, delivered the Honorary Fellow Award Lecture, “The Imperative to Focus on the Prevention of Atrial Fibrillation,” as the recipient of this year’s Honorary Fellow of the American Society for Preventive Cardiology award.
Listen
Posters Characterize DMD Caregiver Experiences, Impact of Gene Therapy on Caregiving Demands
May 10th 2024Posters presented at the ISPOR—The Professional Society for Health Economics and Outcomes Research meeting explored Duchenne muscular dystrophy (DMD) caregiver experiences and gene therapy’s impact on work opportunities for caregivers.
Read More
Promoting Equity in Public Health: Policy, Investment, and Community Engagement Solutions
June 28th 2022On this episode of Managed Care Cast, we speak with Georges C. Benjamin, MD, executive director of the American Public Health Association, on the core takeaways of his keynote session at AHIP 2022 on public health policy and other solutions to promote equitable health and well-being.
Listen
Budesonide-Based Triple Therapy Shows Best Benefit Over Dual Therapy for COPD
May 8th 2024The triple therapy of budesonide, glycopyrrolate, and formoterol fumarate showed the greatest incremental net benefit among a series of triple therapy medications that were evaluated against dual therapy for chronic obstructive pulmonary disease (COPD), according to an analysis presented at ISPOR.
Read More
